Codexis to Report Third Quarter 2023 Financial Results on November 2
October 19 2023 - 4:05PM
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,
today announced that it will report its financial results for the
third quarter of 2023 on Thursday, November 2, 2023, following the
close of market. Codexis management will host a conference call and
webcast at 4:30 pm Eastern Time to discuss the Company’s financial
results and provide a business update.
Participants may access the live webcast on the Codexis
Investor Relations website, where it will be archived for 90 days.
The live call can be accessed by dialing (877) 705-2976 (domestic)
or (201) 689-8798 (international). A telephone replay of the call
will be available for 48 hours by dialing (877) 660-6853 (domestic)
or (201) 612-7415 (international), access ID #13726635.
About Codexis
Codexis is a leading enzyme engineering company leveraging its
proprietary CodeEvolver® technology platform to discover, develop
and enhance novel, high-performance enzymes and other classes of
proteins. Codexis enzymes solve for real-world challenges
associated with small molecule pharmaceuticals manufacturing and
nucleic acid synthesis. The Company is currently developing its
proprietary ECO Synthesis™ platform to enable the scaled
manufacture of RNAi therapeutics through an enzymatic route.
Codexis’ unique enzymes can drive improvements such as higher
yields, reduced energy usage and waste generation, improved
efficiency in manufacturing and greater sensitivity in genomic and
diagnostic applications. For more information,
visit https://www.codexis.com.
For More Information
Investor ContactCarrie McKim(336) 608-9706ir@codexis.com
Media ContactLauren Musto(781) 572-1147media@codexis.com
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jul 2023 to Jul 2024